Health Advances

Today marks the beginning of #PrideMonth! Health Advances stands with the LGBTQIA+ community in the ongoing fight for equality. This month, and every month, we celebrate love, diversity, and the courage to be unapologetically yourself. Together, let’s continue to help create a world where everyone feels seen, valued, and respected. #LoveIsLove #EqualityForAll

Health Advances Life Science Tools & Services Partner Daniela Hristova-Neeley was recently quoted in a 360Dx article, commenting on the challenges and advancements in #multiomics research. As we delve deeper into understanding complex biological systems, integrating various omics data types becomes crucial. Daniela’s expertise shines a light on the importance of strategic data analysis in this rapidly evolving landscape. Read the article here: https://bit.ly/3Vjo9Ey #LifeScienceTools #Diagnostics

Will we see you in sunny San Diego for #BIO2024? Vivek Mittal and Ned Wydysh are looking forward to a productive conference and catching up with friends and colleagues! Plus, Ned will be participating in a panel on How to De-Risk Drug Development from the Earliest Stages – stay tuned for more info.

Attending the DTA Summit next week? Don’t miss Health Advances #DigitalHealth and #DigitalTherapeutics expert, Jeffrey Abraham, as he moderates a panel about the implications of regulatory status on business models and the considerations for digital therapeutics, empowering digital health and #biopharma executives to make informed strategic decisions. Schedule time to meet with Jeff: https://bit.ly/3KiJkAu Digital Therapeutics Alliance

Health Advances #DigitalHealth and Enterprise #HIT expert, Greg Chittim, will be attending the Digital Healthcare Innovation Summit next week! Find time to catch up in Boston here: https://bit.ly/3Vje2jf #DHISEAST

This Memorial Day, Health Advances remembers and honors the brave service members who courageously served our country. We are deeply grateful for their sacrifices. #MemorialDay #RememberAndHonor

Giving back is one of Health Advances core values. Every year, we take a pause from client projects to collaborate for local charitable organizations, in honor of our founders, Mark Speers and Paula Ness Speers, who instilled these values since our inception over 30 years ago. This week, we are spotlighting our #Boston-area office’s “Founders Day”, where we partnered with Cradles to Crayons to sort and pack clothing for children in need. Stay tuned for more as we highlight each of our office’s community service days and share impactful highlights of our #probono work in #SanFrancisco, #ZugSwitzerland, and #HongKong. #HealthAdvancesGivesBack

The announcement of FDA’s #oncology dose optimization initiative, #ProjectOptimus, is a long-coming step towards improving dosing of targeted oncology therapies. With this initiative, the #FDA extends guidance on clinical trial design for targeted therapies. While these guidelines should improve patient safety and QOL, the long-term implications for the commercialization of anticancer drugs are still unfolding. In our most recent blog, we discuss the potential commercial ramifications of Project Optimus, drawing on recent analogs including #lumakras, and highlight the possible impacts on the targeted therapy pipeline. Read here: https://bit.ly/3K752r9 Vivek Mittal, Gary Gustavsen, Ned Wydysh, Earl Gillespie, Arpit Dave, Ph.D., Ashley Peake

Health Advances Partner Gary Gustavsen and Senior Director Earl Gillespie will be heading to Chicago for #ASCO24! Be sure to check out our online abstract on multi-cancer early detection tests in collaboration with AstraZeneca and Personalized Medicine Coalition. https://bit.ly/4bENpdQ #oncology #precisionmedicine

If the recent acquisitions of Axonics, Inc. and Shockwave Medical are any indication, innovators that can balance growth with the upfront investment needed to introduce a new technology will be rewarded. However, many new device companies struggle to overcome the remarkably expensive investments required to win over patients, surgeons, and payers. In our latest blog, we highlight the commercial investments that took seven recently launched products to market. Whether a company has a truly novel product or is entering an established market, there are significant costs that come with commercial launch of #medicaldevices. At Health Advances, we frequently help clients prioritize areas of investment and craft pragmatic commercial launch plans. Read here: https://bit.ly/3ykK9WR #medtech #commercialization Authors: Tracy Walters, Andrew Millar, Russ Rapaport Boston Scientific, Johnson & Johnson, NeuroPace, Inspire Medical Systems, Inari Medical, Pulmonx Corporation